genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Big Data
A Unicorn Rivalry Shaping the Future of the Synbio Industry
Gene Therapy
At Orchard, Moving from Pruning to Planting
GEN Edge
Massachusetts Biopharma Industry Weathers COVID-19 Impacts on Jobs, Financing
AstraZeneca
Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch
Coronavirus
Rough Surf Ahead for California
News
News
Enzyme Identified that May Provide Novel Therapeutic Approach to Huntington’s
Cancer
Epigenetic Regulation Key to Daily Formation of Billions of Blood Cells
Antibodies
Gut Microbiome Influences B Cell and Antibody Repertoire
Cancer
Innate Immune System Triggered by TLK Protein Inhibition
OMICs
New Model May Help in Successfully Translating Data from Animal Studies…
Insights
All
Trends for 2020
Bioprocessing
Remote Control of CAR T Cells to Enhance Safety
Bioprocessing
Standardizing Cell and Gene Therapy Remains Bioindustry Goal
Bioprocessing
COVID-19 Increases Demand for Next-Generation Bioprocessing Technology
Bioprocessing
Moving Quickly but Smartly from R&D to Commercialization
A-Lists
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Cancer
Epigenetic Regulation Key to Daily Formation of Billions of Blood Cells
Antibodies
Gut Microbiome Influences B Cell and Antibody Repertoire
Big Data
A Unicorn Rivalry Shaping the Future of the Synbio Industry
Cancer
Innate Immune System Triggered by TLK Protein Inhibition
Magazine
July 2020 Vol. 40 No. 7
Rosalind Franklin the Scientist
July 2020 Vol. 40 No. 7
COVID-19 Research: Women Are Changing the Face of the Pandemic
July 2020 Vol. 40 No. 7
CRISPR Screening Explores New Dimensions
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Commentary
Clues to Healthier Aging in Cellular Senescence
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Tutorial
In-Depth GPCR Signaling Characterization for Improved Drug Discovery
New Products
Precoated Plates
New Products
Liquid Chromatograph Mass Spectrometer
New Products
RNA Quantification Assay
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
AstraZeneca
AstraZeneca
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AstraZeneca
AstraZeneca, Daiichi Sankyo Target TROP2 in Up-to-$6B Cancer Collaboration
AstraZeneca
Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch
AstraZeneca
AstraZeneca, U. of Oxford Report Positive Phase I/II Data for COVID-19 Vaccine Candidate
AstraZeneca
AstraZeneca Bolsters Manufacturing Capacity, Support for COVID-19 Vaccine
AstraZeneca
AstraZeneca, Accent Launch up to $1.1B+ Cancer Collaboration Targeting RNA-Modifying Proteins
AstraZeneca
AstraZeneca Joins U. of Oxford and Spinout to Develop COVID-19 Vaccine
AstraZeneca
Allergan Sells Zenpep, Brazikumab as Regulators Review AbbVie $63B Deal
AstraZeneca
AstraZeneca to Create $1B Fund, R&D Centers in China
AstraZeneca
AveXis to Acquire AstraZeneca Manufacturing Site in Longmont, CO
AstraZeneca
AstraZeneca, Daiichi Sankyo Launch Potentially $6.9B+ Collaboration to Develop Cancer ADC
AstraZeneca
Moderna Raises Size of its Largest-Ever Biotech IPO to $600M
AstraZeneca
AstraZeneca’s Imfinzi Fails 2nd Primary Endpoint in Phase III MYSTIC Trial
AstraZeneca
Sobi Buys Synagis U.S. Rights, Half Share of MEDI18897 U.S. Profits...
AstraZeneca
Grünenthal Acquires Partial Rights to Nexium, Vimovo from AstraZeneca for Up-to-$922M
AstraZeneca
After Second Phase III Failure, AstraZeneca Retreats from COPD Filing Plans...
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
